#Type2 #diabetes ๐ฉ๐ญ๐ฐ: a new therapeutic molecule as effective as GLP-1R receptor agonists but without the side effects? Cbi-Ex4 tested in #shrews improves #glycemia without #nausea ๐คข #vomiting ๐คฎor #weight loss ๐๐ https://t.co/suquVCH278 pic.twitter.com/WSGvNidB4m
— Gircor, recherche animale et alternatives (@GIRCOR) July 3, 2020